Dr. Jeffrey R. Jay, M.D. »

Scynexis shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Scynexis (SCYX) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Scynexis

Tip: Access up to 7 years of quarterly data

All positions including Scynexis held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Scynexis by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.9M 7.6M 0.92

More positions owned by Dr. Jeffrey R. Jay, M.D.

Apogee Therapeutics (APGE)
Vor Biopharma Com New (VOR)
Zura Bio Class A Ord Shs (ZURA)
Amylyx Pharmaceuticals (AMLX)
Immunitybio Put Option (IBRX)
Nektar Therapeutics Com New (NKTR)
Sol-gel Technologies Shs New (SLGL)
Alumis (ALMS)
Bright Minds Biosciences Com New (DRUG)
Annexon (ANNX)
Kalvista Pharmaceuticals (KALV)
Immunovant (IMVT)
Jade Biosciences Com New (JBIO)
Contineum Therapeutics Cl A (CTNM)
Zenas Biopharma (ZBIO)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Scynexis

Squadron Capital Management
Dr. Jeffrey R. Jay, M.D.
Avidity Partners Management
Kingdon Capital Management
Empery Asset Management
Vanguard Group
Vanguard Capital Management
DAFNA Capital Management
Acadian Asset Management
Millennium Management
Geode Capital Management
BlackRock
Vanguard Fiduciary Trust
Yakira Capital Management
Renaissance Technologies

View all funds holding Scynexis